1. Home
  2. KNSA vs BBSI Comparison

KNSA vs BBSI Comparison

Compare KNSA & BBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNSA
  • BBSI
  • Stock Information
  • Founded
  • KNSA 2015
  • BBSI 1965
  • Country
  • KNSA United Kingdom
  • BBSI United States
  • Employees
  • KNSA N/A
  • BBSI N/A
  • Industry
  • KNSA Biotechnology: Pharmaceutical Preparations
  • BBSI Professional Services
  • Sector
  • KNSA Health Care
  • BBSI Consumer Discretionary
  • Exchange
  • KNSA Nasdaq
  • BBSI Nasdaq
  • Market Cap
  • KNSA 1.3B
  • BBSI 1.1B
  • IPO Year
  • KNSA 2018
  • BBSI 1993
  • Fundamental
  • Price
  • KNSA $18.73
  • BBSI $44.37
  • Analyst Decision
  • KNSA Strong Buy
  • BBSI Buy
  • Analyst Count
  • KNSA 5
  • BBSI 3
  • Target Price
  • KNSA $36.60
  • BBSI $41.67
  • AVG Volume (30 Days)
  • KNSA 469.7K
  • BBSI 98.1K
  • Earning Date
  • KNSA 02-26-2025
  • BBSI 02-26-2025
  • Dividend Yield
  • KNSA N/A
  • BBSI 0.70%
  • EPS Growth
  • KNSA N/A
  • BBSI 10.06
  • EPS
  • KNSA N/A
  • BBSI 1.89
  • Revenue
  • KNSA $384,098,000.00
  • BBSI $1,116,393,000.00
  • Revenue This Year
  • KNSA $60.05
  • BBSI $8.11
  • Revenue Next Year
  • KNSA $36.74
  • BBSI $7.27
  • P/E Ratio
  • KNSA N/A
  • BBSI $23.41
  • Revenue Growth
  • KNSA 54.41
  • BBSI 4.87
  • 52 Week Low
  • KNSA $16.56
  • BBSI $27.06
  • 52 Week High
  • KNSA $28.15
  • BBSI $44.97
  • Technical
  • Relative Strength Index (RSI)
  • KNSA 38.56
  • BBSI 62.19
  • Support Level
  • KNSA $18.27
  • BBSI $40.92
  • Resistance Level
  • KNSA $19.05
  • BBSI $44.97
  • Average True Range (ATR)
  • KNSA 0.61
  • BBSI 1.00
  • MACD
  • KNSA -0.05
  • BBSI 0.14
  • Stochastic Oscillator
  • KNSA 34.42
  • BBSI 85.19

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of payroll administrative services and staffing services. The company categories of services include professional employer services and staffing. Professional employer services offer payroll management, payroll tax services, and workers' compensation coverage solutions, as well as workforce management services, including hiring and termination of employees. Staffing offers temporary staffing services, as well as contract staffing, long-term or indefinite on-site management, and direct placement services. The company operates in the United States of America. It generates maximum revenue from the Professional employer service fees.

Share on Social Networks: